Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

NCT00043927 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

760

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: topotecan/cisplatin
DRUG: etoposide/cisplatin

Sponsor

GlaxoSmithKline